U.S. Stocks Diverge as Investors Weigh Fed Rate Plan
Dow, S&P fall while Nasdaq rises. Gold futures decline 4.5%. CureVac shares plunge 40% on disappointing Covid-19 vaccine trial. J.R. Whalen reports.
Learn more about your ad choices. Visit megaphone.fm/adchoices
